Synthesis, in vitro, and in silico studies of morpholine-based thiosemicarbazones as ectonucleotide pyrophosphatase/ phosphodiesterase-1 and-3 inhibitors

dc.contributor.authorTasleem, Mussarat
dc.contributor.authorPelletier, Julie
dc.contributor.authorSevigny, Jean
dc.contributor.authorHussain, Zahid
dc.contributor.authorKhan, Ajmal
dc.contributor.authorAl-Harrasi, Ahmed
dc.contributor.authorEl-kott, Attalla F.
dc.date.accessioned2025-10-18T10:11:13Z
dc.date.created2024
dc.date.issued2024
dc.departmentBartın Üniversitesi
dc.description.abstractAn extensive range of new biologically active morpholine based thiosemicarbazones derivatives 3a-r were synthesized, characterized by spectral techniques and evaluated as inhibitors of ENPP isozymes. Most of the novel thiosemicarbazones exhibit potent inhibition towards NPP1 and NPP3 isozymes. Compound 3 h was potent inhibitor of NPP1 with IC 50 value of 0.55 +/- 0.02. However, the most powerful inhibitor of NPP3 was 3e with an IC 50 value of 0.24 +/- 0.02. Furthermore, Lineweaver-Burk plot for compound 3 h against NPP1 and for compound 3e against NPP3 was devised through enzymes kinetics studies. Molecular docking and in silico studies was also done for analysis of interaction pattern of all newly synthesized compounds. The results were further validated by molecular dynamic (MD) simulation where the stability of conformational transformation of the best proteinligand complex ( 3e ) were justified on the basis of RMSD and RMSF analysis.
dc.description.sponsorshipDeanship of Scientific Research at King Khalid University [RGP2/227/44]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2023-05498]; Alexander von Humboldt Foundation
dc.description.sponsorshipThe authors extend their appreciation to the Deanship of Scientific Research at King Khalid University for funding this work through large group Research Project under grant number RGP2/227/44. J.S. received support from the Natural Sciences and Engineering Research Council of Canada (NSERC; RGPIN-2023-05498) . Z. S is thankful to the Alexander von Humboldt Foundation for the award of Georg Forster Research Fellowship for Experienced Researchers.
dc.identifier.doi10.1016/j.ijbiomac.2024.131068
dc.identifier.issn0141-8130
dc.identifier.issn1879-0003
dc.identifier.orcidHussain, Zahid/0000-0001-5820-2471
dc.identifier.orcidNegm, Sally/0000-0001-8057-2022
dc.identifier.orcidShafiq, Zahid/0000-0003-4088-8297
dc.identifier.orcidSevigny, Jean/0000-0003-2922-1600;
dc.identifier.pmid38531526
dc.identifier.scopus2-s2.0-85189564412
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1016/j.ijbiomac.2024.131068
dc.identifier.urihttps://hdl.handle.net/11772/22260
dc.identifier.volume266
dc.identifier.wosWOS:001216399000001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofInternational Journal of Biological Macromolecules
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzWoS_20251016
dc.subjectThiosemicarbazones
dc.subjectEctonucleotide Pyrophosphatase
dc.subjectMolecular Docking
dc.titleSynthesis, in vitro, and in silico studies of morpholine-based thiosemicarbazones as ectonucleotide pyrophosphatase/ phosphodiesterase-1 and-3 inhibitors
dc.typeArticle
dspace.entity.typePublication

Dosyalar